Skip to main content
Livermore
Livermore
ZHEN

Federated Hermes, Inc.

SEC CIK
0001056288
Latest filing
Aug 12, 2026

The latest 13F from Federated Hermes, Inc. covers Q2 2026 (filed Aug 12, 2026): 2,038 long positions worth $69.6B. The top 10 holdings make up 16.2% of the portfolio, and the largest is NVIDIA Corp (NVDA) at 2.7%. Livermore has 23 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
174
Est. +$884.6M
Added
863
Est. +$11.2B
Reduced
911
Est. −$11.0B
Sold out
185
Est. −$331.6M

Top 5 holdings

Share of this quarter's portfolio value

  1. NVDANVIDIA Corp
    2.7%$1.90BHistory
  2. AAPLApple Inc.
    2.6%$1.77BHistory
  3. GOOGLAlphabet Inc.
    2.0%$1.37BHistory
  4. ABBVAbbVie Inc.
    1.6%$1.12BHistory
  5. MSFTMicrosoft Corp
    1.4%$975.7MHistory

Share of portfolio

Top 5 holdings and the other 2,033 positions, by share of portfolio value

  1. NVDA2.7%
  2. AAPL2.6%
  3. GOOGL2.0%
  4. ABBV1.6%
  5. MSFT1.4%
  6. Other 2,033 positions89.7%

Biggest buys

New and added positions, by estimated amount bought

  1. AAPLApple Inc.
    +$440.7MAddedHistory
  2. RFRegions Financial Corp
    +$337.2MAddedHistory
  3. ALABAstera Labs, Inc.
    +$321.7MAddedHistory
  4. ADPAutomatic Data Processing Inc
    +$302.3MAddedHistory
  5. MUMicron Technology Inc
    +$257.2MAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. MUMicron Technology Inc
    +0.89 pp0.3% → 1.1%History
  2. AAPLApple Inc.
    +0.65 pp1.9% → 2.6%History
  3. ALABAstera Labs, Inc.
    +0.60 pp<0.1% → 0.7%History
  4. AMDAdvanced Micro Devices Inc
    +0.52 pp0.1% → 0.6%History
  5. RFRegions Financial Corp
    +0.48 pp<0.1% → 0.5%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. TERTeradyne, Inc
    −$410.7MReducedHistory
  2. GOOGLAlphabet Inc.
    −$387.6MReducedHistory
  3. UNHUnitedHealth Group Inc
    −$321.5MReducedHistory
  4. TFCTruist Financial Corp
    −$317.3MReducedHistory
  5. HBANHuntington Bancshares Inc
    −$230.6MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. CVXChevron Corp
    −0.61 pp1.2% → 0.6%History
  2. TFCTruist Financial Corp
    −0.49 pp0.8% → 0.3%History
  3. MSFTMicrosoft Corp
    −0.40 pp1.8% → 1.4%History
  4. XOMExxonMobil Holdings Corp
    −0.33 pp0.5% → 0.2%History
  5. HBANHuntington Bancshares Inc
    −0.33 pp0.3% → <0.1%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$69.6B
+$8.07B (+13.1%) vs. prior quarter
Positions
2,038
−11 vs. prior quarter
Top 10 concentration
16.2%
Top 10 as share of value
Turnover
17.3%
Q2 2026, one quarter
Average holding period
18.5 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $69.6B (Q2 2026)

Q1 2021: $51.4BQ2 2021: $53.6BQ3 2021: $52.5BQ4 2021: $53.6BQ1 2022: $44.3BQ2 2022: $36.8BQ3 2022: $34.1BQ4 2022: $36.1BQ1 2023: $39.7BQ2 2023: $40.3BQ3 2023: $37.5BQ4 2023: $40.3BQ1 2024: $43.4BQ2 2024: $42.2BQ3 2024: $45.5BQ4 2024: $45.7BQ1 2025: $46.4BQ2 2025: $53.1BQ3 2025: $56.6BQ4 2025: $59.9BQ1 2026: $61.5BQ2 2026: $69.6B
Q1 2021Q2 2026
13F filings of Federated Hermes, Inc. by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 12, 20262,038$69.6BNVDAAAPLGOOGLvs. Q1 2026SEC
Q1 2026May 11, 20262,049$61.5BNVDAGOOGLAAPLvs. Q4 2025SEC
Q4 2025Feb 12, 20262,063$59.9BNVDAMSFTGOOGLvs. Q3 2025SEC
Q3 2025Nov 3, 20252,113$56.6BNVDAMSFTGOOGLvs. Q2 2025SEC
Q2 2025Aug 13, 20252,054$53.1BMSFTNVDAAMZNvs. Q1 2025SEC
Q1 2025May 8, 20252,050$46.4BMSFTNVDAAAPLvs. Q4 2024SEC
Q4 2024Feb 13, 20252,067$45.7BMSFTNVDAAMZNvs. Q3 2024SEC
Q3 2024Nov 13, 20242,054$45.5BMSFTNVDAVZvs. Q2 2024SEC
Q2 2024Aug 8, 20242,019$42.2BMSFTNVDAPMvs. Q1 2024SEC
Q1 2024May 14, 20242,021$43.4BMSFTVZPMvs. Q4 2023SEC
Q4 2023Jan 31, 20242,035$40.3BMSFTPMVZvs. Q3 2023SEC
Q3 2023Nov 13, 20232,084$37.5BPMMSFTAMGNvs. Q2 2023SEC
Q2 2023Aug 14, 20232,089$40.3BPMAAPLVZvs. Q1 2023SEC
Q1 2023May 8, 20232,111$39.7BPMVZAAPLvs. Q4 2022SEC
Q4 2022Feb 13, 20232,151$36.1BPMGILDVZvs. Q3 2022SEC
Q3 2022Nov 14, 20222,132$34.1BVZPMAAPLvs. Q2 2022SEC
Q2 2022Sep 16, 2022Amended2,127$36.8BVZPMMSFTvs. Q1 2022SEC
Q1 2022May 13, 20222,167$44.3BMSFTAAPLABBVvs. Q4 2021SEC
Q4 2021Feb 14, 20222,195$53.6BTSMMSFTAAPLvs. Q3 2021SEC
Q3 2021Nov 15, 20212,201$52.5BTSMMSFTMRKvs. Q2 2021SEC
Q2 2021Aug 16, 20212,189$53.6BTSMMSFTPMvs. Q1 2021SEC
Q1 2021May 13, 20212,207$51.4BTSMPMMSFT–SEC

13D and 13G filings

Companies where Federated Hermes, Inc. reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

7 companies, largest stake first.

Companies where Federated Hermes, Inc. owns 5% or more
CompanyLatest formStakeChangeFirst filedLatest filingFiling
NERVMinerva Neurosciences, Inc.13G/A17.17%8.69M shares−2.69 ppfrom 19.86%Feb 12, 20217 filingsJul 8, 2026SEC
ARCTArcturus Therapeutics Holdings Inc.13G/A11.63%3.30M shares–Jan 8, 20215 filingsJan 8, 2026SEC
ATYRaTYR PHARMA INC13G/A8.68%8.51M shares−2.08 ppfrom 10.76%Feb 12, 202110 filingsJul 8, 2026SEC
EYPTEyePoint, Inc.13G/A6.68%4.60M shares–Nov 6, 20242 filingsJul 8, 2025SEC
LFMDLifeMD, Inc.13G5.68%2.75M sharesNewJul 8, 20261 filingJul 8, 2026SEC
TTECTTEC Holdings, Inc.13G5.24%2.54M sharesNewJan 8, 20261 filingJan 8, 2026SEC
AAPAdvance Auto Parts Inc13G5.06%3.04M sharesNewApr 7, 20261 filingApr 7, 2026SEC

Latest filings

208 filings on file made by Federated Hermes, Inc. or listing it as a reporting person; the latest 20 are shown.

Schedule 13D and 13G filings by Federated Hermes, Inc.
CompanyFiled (ET)FormStakeChangeEvent dateFiling
FBRXForte Biosciences, Inc.Sep 8, 202611:10 AM ET13G/A0.00%0 shares−10.31 ppfrom 10.31%Below 5%Aug 31, 2026SEC
SCYXScynexis IncJul 20, 20262:47 PM ET13G/A4.03%441.7K shares−0.42 ppfrom 4.45%Below 5%Jun 30, 2026SEC
SCYXScynexis IncJul 8, 20267:57 AM ET13G/A4.45%55.2K shares−3.97 ppfrom 8.42%Below 5%Jun 30, 2026SEC
OVIDOvid Therapeutics Inc.Jul 8, 20267:54 AM ET13G/A4.15%7.74M shares−1.79 ppfrom 5.94%Below 5%Jun 30, 2026SEC
NERVMinerva Neurosciences, Inc.Jul 8, 20267:51 AM ET13G/A17.17%8.69M shares−2.69 ppfrom 19.86%Jun 30, 2026SEC
MGPIMGP Ingredients IncJul 8, 20267:49 AM ET13G/A4.59%980.1K shares−1.00 ppfrom 5.59%Below 5%Jun 30, 2026SEC
LFMDLifeMD, Inc.Jul 8, 20267:45 AM ET13G5.68%2.75M sharesNewJun 30, 2026SEC
FBRXForte Biosciences, Inc.Jul 8, 20267:42 AM ET13G/A10.31%2.11M shares−2.84 ppfrom 13.15%Jun 30, 2026SEC
ATYRaTYR PHARMA INCJul 8, 20267:37 AM ET13G/A8.68%8.51M shares−2.08 ppfrom 10.76%Jun 30, 2026SEC
SSTISoundthinking, Inc.Apr 7, 20267:50 AM ET13G/A3.47%450.0K shares−4.35 ppfrom 7.82%Below 5%Mar 31, 2026SEC
SDHCSmith Douglas Homes Corp.Apr 7, 20267:49 AM ET13G/A2.86%258.9K shares–Below 5%Mar 31, 2026SEC
MGPIMGP Ingredients IncApr 7, 20267:24 AM ET13G/A5.59%1.19M shares−1.16 ppfrom 6.75%Mar 31, 2026SEC
AAPAdvance Auto Parts IncApr 7, 20267:22 AM ET13G5.06%3.04M sharesNewMar 31, 2026SEC
TTECTTEC Holdings, Inc.Jan 8, 202612:06 PM ET13G5.24%2.54M sharesNewDec 31, 2025SEC
OVIDOvid Therapeutics Inc.Jan 8, 202611:56 AM ET13G5.94%7.74M sharesNewDec 31, 2025SEC
SCYXScynexis IncJan 8, 20268:19 AM ET13G/A8.42%3.53M shares−2.84 ppfrom 11.26%Dec 31, 2025SEC
MGPIMGP Ingredients IncJan 8, 20268:17 AM ET13G/A6.75%1.44M shares+1.58 ppfrom 5.17%Dec 31, 2025SEC
IDYAIDEAYA Biosciences, Inc.Jan 8, 20268:15 AM ET13G/A3.87%3.40M shares–Below 5%Dec 31, 2025SEC
ARCTArcturus Therapeutics Holdings Inc.Jan 8, 20268:12 AM ET13G/A11.63%3.30M shares–Dec 31, 2025SEC
NERVMinerva Neurosciences, Inc.Dec 29, 20258:29 AM ET13G19.86%9.39M shares+0.54 ppfrom 19.32%Dec 22, 2025SEC